1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Poultry Diagnostic Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Poultry Diagnostic Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. North America Poultry Diagnostic Market Regional Analysis
6.1 North America Poultry Diagnostic Market Overview
6.2 North America Poultry Diagnostic Market Revenue 2020-2030 (US$ Million)
6.3 North America Poultry Diagnostic Market Forecast Analysis
7. North America Poultry Diagnostic Market Analysis – by Test Type
7.1 Enzyme-Linked Immunosorbent Assay Tests
- 7.1.1 Overview
- 7.1.2 Enzyme-Linked Immunosorbent Assay Tests: North America Poultry Diagnostic Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Polymerase Chain Reaction Test
- 7.2.1 Overview
- 7.2.2 Polymerase Chain Reaction Test: North America Poultry Diagnostic Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Hemagglutination-Inhibition
- 7.3.1 Overview
- 7.3.2 Hemagglutination-Inhibition: North America Poultry Diagnostic Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Poultry Diagnostic Market Analysis – by Disease
8.1 Avian Salmonellosis
- 8.1.1 Overview
- 8.1.2 Avian Salmonellosis: North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Avian Influenza
- 8.2.1 Overview
- 8.2.2 Avian Influenza: North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Newcastle Disease
- 8.3.1 Overview
- 8.3.2 Newcastle Disease: North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Avian Mycoplasmosis
- 8.4.1 Overview
- 8.4.2 Avian Mycoplasmosis: North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Infectious Bronchitis
- 8.5.1 Overview
- 8.5.2 Infectious Bronchitis: North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Poultry Diagnostic Market – North America Analysis
9.1 North America
- 9.1.1 North America Poultry Diagnostic Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 9.1.1.1 North America Poultry Diagnostic Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
- 9.1.1.1.1 US: North America Poultry Diagnostic Market Breakdown, by Test Type
- 9.1.1.1.2 US: North America Poultry Diagnostic Market Breakdown, by Disease
- 9.1.1.2 Canada:
North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
- 9.1.1.2.1 Canada: North America Poultry Diagnostic Market Breakdown, by Test Type
- 9.1.1.2.2 Canada: North America Poultry Diagnostic Market Breakdown, by Disease
- 9.1.1.3 Mexico :
North America Poultry Diagnostic Market – Revenue and Forecast to 2030 (US$ Million)
- 9.1.1.3.1 Mexico : North America Poultry Diagnostic Market Breakdown, by Test Type
- 9.1.1.3.2 Mexico : North America Poultry Diagnostic Market Breakdown, by Disease
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Poultry Diagnostic Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Idexx Laboratories Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Qiagen NV
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Eurofins Scientific SE
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Boehringer Ingelheim International GmbH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Zoetis Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 BioCheck BV
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Bioneer Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights